Skip to main content
Premium Trial:

Request an Annual Quote

NHLBI Seeks Input on Systems Biology Approaches to Disease

NEW YORK, Feb. 7 (GenomeWeb News) - The National Heart, Lung, and Blood Institute has issued a request for information seeking "comments and ideas on the development and application of systems biology approaches to heart, lung, blood, and sleep disorders."

The NHLBI said it is looking for help in identifying major opportunities to develop and apply systems biology approaches to heart, lung, blood, and sleep research and medicine; in gauging the interest and readiness of the heart, lung, blood, and sleep research community to engage in systems biology research; pinpointing the needs for developing and supporting systems biology research in the heart, lung, blood, and sleep research community and barriers that may inhibit it; and finding practical and effective ways to meet these needs and overcome these barriers.

"This request for information is for planning purposes only and shall not be construed as a solicitation for applications or as an obligation on the part of the government," the NHLBI said. "The government will not pay for the preparation of any information submitted or the government's use of that information."

 

Additional details about the institute's request can be found here.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.